The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify susceptible patients. (2011)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-61779-270-0_15
PubMed Identifier: 21870265
Publication URI: http://europepmc.org/abstract/MED/21870265
Type: Journal Article/Review
Volume: 780
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745